Clinical trial
Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic…
NCT00278525 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00278525 |
|---|---|
| Title | Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma |
| Official title | Trial of High Dose Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG) With Hematopoietic Stem Cell Support in Patients With Systemic Scleroderma: A Randomized Trial |
| Lead sponsor | Northwestern University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | SYSTEMIC SCLERODERMA |
| Intervention type | Drug, Procedure |
| Interventions | standard of care, stem cell transplantation |
| Enrollment | 19 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2011 |
| Completion | Dec 1, 2012 |
| First posted | Jan 18, 2006 |
| Last update posted | Apr 30, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: